Table 2

Overt signs observed in male Sprague-Dawley rats after oral administration of DMP 543, XE991 or linopirdine

SignCompoundDose (mg/kg, po)Number
TremorsDMP 5430.6254 /20
1.25015 /20
XE9916.25014 /15
12.50010 /10
linopirdine12.5008 /10
25.0008 /10
Loss of LiftDMP 5430.6250 /20
1.2500 /20
XE9916.2502 /15
12.5006 /10
linopirdine12.5000 /10
25.0002 /10
DiarrheaDMP 5430.6255 /20
1.2500 /20
XE9916.2500 /10
12.5000 /10
linopirdine12.5000 /10
25.0003 /10
Curled ToesDMP 5430.6250 /20
1.2500 /20
XE9916.2500 /10
12.5000 /10
linopirdine12.5000 /10
25.0003 /10
  • Number refers to the number of animals observed showing the sign over the number of animals receiving that dose of compound. Effects on other measures were not observed. These measures as stated in “Methods,” included righting reflex, corneal reflex, placing reflex, myotatic reflex, loss of grip, exploratory loss, alterations in muscle tone, ptosis, catatonia, salivation, lacrimation, excitement, convulsion and mortality.